. The study was performed in accordance with the Declaration of Helsinki. The patients with ALL, AML, and MDS and 200 ethnically matched non-leukemic controls signed appropriate informed consent to participate. The use of the material was reviewed and approved by the local institutional review board (IRB) of The Catholic University of Korea, with written informed consent obtained for all samples collected (IRB Number: SCMC07BR131). DNA was isolated from peripheral blood. We applied sequence-based typing (PCR-SBT) as an authentication method to amplify the exons 2-5 of MICA 7 . Genotyping was performed by PCR-SBT 4 for MICA-129 alleles (A to G) in exon 3 at position 454 of the MICA gene. MICB primers were designed based on exons 2-4 for genotyping of MICB-sequence alleles 8 . The χ 2 test and Fisher's exact test were used to determine statistical significance. P-values were corrected (P c ) using the Bonferroni's method. The odds ratio (OR) was calculated using Haldane's modification of Woolf's method. Hardy-Weinberg equilibrium in controls was analyzed for each SNP using SNPStats on the website (http://bioinfo. iconcologia.net/snpstats/start.htm) (P > 0.05).
In total patients, the frequencies of MICA*002:01 alleles and A9 alleles were higher than in controls (112 of 324 Table 1) .
As an important ligand of human NKG2D, an activating cell surface receptor expressed on NK and T cells, the MICA protein is expressed on several tumors, especially epithelium-derived cancer cells 5 . Ligand binding of MICA to the NKG2D receptor activates the innate immune response by stimulating NK and γδT cells. Tumor cells expressing high levels of membrane MICA and other NKG2D ligands are rejected by NK and CD8αβT cells, thereby stimulating antitumor activity, while reduced expression of membrane MICA as well as increased soluble MICA in serum leads to inactivation of the NKG2D-mediated antitumor response 9 . Recently, it has been shown that soluble NKG2D ligands can activate NKG2D-dependent signaling, rather than lead to NK cytotoxicity experiments have shown that this downregulation-resisting allele, MICA*008:01, is functionally relevant and may aid in the elimination of virusinfected cells. MICA*008:01 and A5.1 are the most common alleles in population studies 2 . We can infer that, at least to some extent, the allelic repertoire of MICA represents an evolutionary record of past pathogen-driven selection and that the protective role of MICA*008:01 and A5.1 casts a 'selective' effect on the distribution of this allele.
Although the MICA-129 val/val genotype and elevated sMICA serum levels post-HSCT are independently associated with the incidence of cGVHD (P = 0.002 and 0.001), regardless of the history of acute GVHD, the presence of MICA Abs before transplantation confers protection against cGVHD (P = 0.04) 4 . There is an inverse relationship between UC or cGVHD and total patients including ALL, suggesting that these genetic characteristics of MICA influence disease incidence.
With the typing of MICA*002:01, MICA*008:01, and MICB*005:03 alleles associated with ALL, AML, and MDS using previously developed microarrays 11, 12 , it will be possible to predict within more short time whether they are at risk or not. Furthermore, the investigation of MIC alleles in individual tumor samples, at the level of protein expression, should be of further interest. Our results illustrate that MICA-NKG2D played a role in disease pathogenesis in the majority of patients in our cohort of cases of ALL, AML, and MDS, and further investigation into this signaling axis may reveal potent therapeutic targets.
